iBio, Inc.
IBIO
$2.22
$0.115.21%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -19.88M | -15.25M | -13.52M | -16.13M | -19.30M |
| Total Depreciation and Amortization | 823.00K | 863.00K | 852.00K | 840.00K | 1.18M |
| Total Amortization of Deferred Charges | -- | -- | -- | 0.00 | 0.00 |
| Total Other Non-Cash Items | 3.26M | 1.00M | 1.10M | 5.75M | 5.03M |
| Change in Net Operating Assets | 271.00K | -768.00K | -639.00K | -2.90M | -3.00M |
| Cash from Operations | -15.52M | -14.15M | -12.20M | -12.44M | -16.09M |
| Capital Expenditure | -549.00K | -34.00K | -2.00K | -211.00K | -211.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 66.00K | 66.00K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -23.88M | -21.42M | 758.00K | 712.00K | 1.71M |
| Cash from Investing | -24.43M | -21.45M | 756.00K | 567.00K | 1.57M |
| Total Debt Issued | -- | -- | -- | 0.00 | 895.00K |
| Total Debt Repaid | -957.00K | -513.00K | -519.00K | -1.58M | -1.72M |
| Issuance of Common Stock | 6.39M | 2.75M | 2.43M | 14.34M | 18.62M |
| Repurchase of Common Stock | -- | -- | -- | 0.00 | 0.00 |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 58.24M | 52.49M | 5.95M | -88.00K | -88.00K |
| Cash from Financing | 63.67M | 54.73M | 7.87M | 12.68M | 17.70M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 23.72M | 19.13M | -3.58M | 807.00K | 3.18M |